Australia Sickle Cell Disease Drug Market Analysis

Australia Sickle Cell Disease Drug Market Analysis

$ 3999$ 2999

Australia's Sickle Cell Disease Drug Market is expected to grow from $1.1 Mn in 2022 to $2.6 Mn in 2030 with a CAGR of 11% for the year 2022-2030. Immigration from other countries such as Africa and the Middle East etc along with newly licensed drugs for the treatment of sickle cell disease is driving the growth of the Australia Sickle Cell Disease Drug Market. the market is segmented by treatment modalities and by distribution channel. Some of the key players in the Australia Sickle Cell Disease Drug Market are Baxter Healthcare, Lipa Pharmaceutical, and Pfizer.

ID: IN10AUPH367 CATEGORY: Pharmaceuticals GEOGRAPHY: Australia AUTHOR: Parul Choudhary

Buy Now

Australia Sickle Cell Disease Drug Market Executive Analysis

Australia's sickle cell disease drug market size is at around $1.1 Mn in 2022 and is projected to reach $2.6 Mn in 2030, exhibiting a CAGR of 11% during the forecast period. In 2022–2023, total health spending in Australia is anticipated to rise by 3.3% to $238.1 Bn. Growth in health spending for the current year has been restrained by the reduction of COVID-19-related expenditures. An increase in Medicare costs, which mostly consist of Medicare and Private Health Insurance Rebate expenses, will, however, spur development in medical services and benefits. Along with this, the Australian Government's financial support for public hospitals is expected to increase as the demand for services rises. Australia's aging population has also continued to be a driving force for health services, which has led to an increase in health spending overall.

Sickle cell disease (SCD) and its variants are hereditary illnesses caused by a mutant form of hemoglobin called hemoglobin S. (HbS). Normal hemoglobin-containing red blood cells are smooth, disk-shaped, and malleable, like doughnuts without holes. They can readily pass through the blood vessels. Sickle cell hemoglobin-containing cells are rigid and sticky. When they run out of oxygen, they take the form of a sickle or a crescent, similar to the letter C. These cells adhere to one another and find it difficult to pass via blood arteries. This may restrict the flow of healthy, regular, oxygen-carrying blood through small blood vessels and this obstruction can be painful.

In comparison to other countries, Australia has a comparatively low incidence of sickle cell disease. Only 400 people in Australia are thought to have sickle cell disease, and most of them are immigrants or their descendants who came from nations where the condition is more common. Monash University's Public Health and Preventative Medicine department runs a program called the Haemoglobinopathy Registry (HbR) to gather information on the incidence of sickle cell disease in Australia. HbR is an Australian national registry for people who have blood disorders, including SCD. An organization called Australian Sickle Cell Advocacy Inc. (ASCA) works to protect the rights of Australians with sickle cell disease as they navigate the country's healthcare system. With pharmaceutical treatment being limited to one medicine in Australia, blood transfusion is one of the most effective therapeutic choices for this disease. For adults and children with sickle cell disease who are 16 years of age or older, crizanlizumab-tmca has been approved. The drug is injected into a vein via an intravenous line, aids in preventing blood cells from adhering to blood vessel walls, and results in blood flow blockage, inflammation, and painful episodes.

australia sickle cell disease drug market analysis

Market Dynamics

Market Growth Drivers

As the immigration of Hispanic Americans of Middle Eastern, Asian, Indian, Mediterranean, South American, and Central American origin rises, SCD prevalence will rise in Australia. With the introduction of some of the products licensed for the treatment of sickle cell disease, such as (Emmaus Life Sciences), the world is experiencing a major surge of innovation, which will eventually cause the Australia Sickle Cell Disease Drug Market to grow.

Market Restraints

Due to the high cost of treatment, sickle cell disease imposes a major financial burden on patients, health insurance companies, and government healthcare programs, limiting Australia's Sickle Cell Disease Drug Market growth. The market's potential is further restricted by the lack of Therapeutics Goods Administration (TGA) approved medications for the treatment of sickle cell disease.

Competitive Landscape

Key Players

  • Aspen (AUS)
  • Allergan (AUS)
  • Baxter Healthcare (AUS)
  • Lipa Pharmaceutical (AUS)
  • Pfizer
  • Sanofi
  • GlaxoSmithKline
  • Novartis
  • Johnson & Johnson

Healthcare Policies and Regulatory Landscape

Australia's citizens, permanent residents, and some expats have access to a variety of medical services and treatments including SCD through the government-funded healthcare system known as Medicare Australia. It covers a wide range of critical medical services, including doctor visits, specialist consultations, diagnostic procedures, and prescription medications. The Australian Department of Health is in charge of and finances Medicare. Although Medicare covers a significant portion of medical expenses, some services could have additional out-of-pocket charges or private health insurance requirements.

The Australian government's Pharmaceutical Benefits Scheme (PBS) program offers subsidized access to a variety of prescription drugs. It is a part of the broader Medicare system and was created to guarantee that Australians have cheap access to the pharmaceuticals they require.

The Australian government agency in charge of monitoring drugs, medical equipment, and other therapeutic products is known as the Therapeutic Goods Administration (TGA). The TGA is part of the Australian Department of Health and is in charge of evaluating pharmaceuticals for safety, quality, and efficacy before they are made accessible for use in Australia.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Sickle Cell Disease Drug Market Segmentation

By Treatment Modality

The pharmacotherapy segment is expected to grow tremendously in the forecasted period as limited treatment options are available in the market.

  • Bone Marrow Transplant
  • Blood Transfusion
  • Pharmacotherapy
  • Hydroxyurea
  • Branded Drugs
  • Endari
  • Adakeveo
  • Oxbryta
  • Zynteglo
  • CTX001
  • Mitapivat
  • FT-4202

By Distribution Channel

The hospital segment is expected to dominate the market throughout the forecast period.

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 18 July 2023

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter